#TempusAIStock
LightNews LightNews
wealthwise-dca.bsky.social
Tempus AI surged after beating Q2 expectations and raising its 2025 revenue guidance for the second time this year.

#TEM #TEMStock #TEMNews #TEMStockNews #TempusAI #TempusAIStock #TempusAINews #TempusAIStockNews #Genomics #HealthTech #Biotech #MarketIntelligence #Investors #WallStreet
$TEM
August 11, 2025 at 4:38 PM
wealthwise-dca.bsky.social
Tempus AI received FDA 510(k) clearance for its Tempus ECG-Low EF software, which uses AI to identify patients with low left ventricular ejection fraction, a key measure of heart function.

#TEM #TEMStock #TEMNews #TEMStockNews #TempusAI #TempusAIStock #TempusAINews #TempusAIStockNews
$TEM
July 17, 2025 at 11:31 AM
wealthwise-dca.bsky.social
Tempus AI, AstraZeneca & Pathos AI Team Up on AI Oncology Model.

#TEM #TEMStock #TEMNews #TEMStockNews #TempusAI #TempusAIStock #TempusAINews #TempusAIStockNews #TempusAIAstraZeneca #AstraZeneca #AZN #AZNStock #PathosAI #Oncology #TempusAIOncology #OncologyAI #CancerAI #TempusAICancer
April 24, 2025 at 11:58 AM